US equities |
SPCX $168.74 ▲+6.15% NVDA $237.71 ▲+1.61% MU $1,064.77 ▼-0.94% TSLA $380.65 ▲+2.71% MSFT $525.00 ▲+1.44% SNDK $1,714.33 ▼-0.33% INTC $116.89 ▼-2.04% META $744.74 ▲+2.29%
FinancialContent

Bio-Rad Laboratories Inc Cl B (NY:BIO-B)

365.08 UNCHANGED
Last Price Updated: 7:00 PM EDT, Aug 20, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Bio-Rad Laboratories Inc Cl B

News headline image
Biodesix partner, Friends of Cancer Research, publishes data in Clinical Cancer Research, demonstrating strong association between ctDNA changes and treatment outcomes for patients with solid tumor types
Aggregate analysis of eight clinical trials of patients with advanced non-small cell lung cancer (aNSCLC) was supported by Biodesix, using Bio-Rad Droplet Digital™ PCR technology 
From Biodesix, Inc.
Via GlobeNewswire